|
Volumn 79, Issue 2, 2010, Pages 129-130
|
Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
a,b,c a,b,c a a a a,b,c a,b,c a,b,c
a
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
OLANZAPINE;
RISPERIDONE;
ADULT;
CLINICAL TRIAL;
COGNITION;
COGNITIVE THERAPY;
CONFOUNDING VARIABLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
EMPLOYMENT STATUS;
FEMALE;
FUNCTIONAL ASSESSMENT;
HUMAN;
HUMAN RELATION;
LETTER;
LINEAR REGRESSION ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
MEMORY DISORDER;
MENTAL DISEASE;
OUTCOME ASSESSMENT;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PRIORITY JOURNAL;
PSYCHOMOTOR DEVELOPMENT;
SCHIZOPHRENIA;
STATISTICAL SIGNIFICANCE;
SYMPTOM;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VERBAL MEMORY;
WORKING MEMORY;
ADULT;
ANTIPSYCHOTIC AGENTS;
CHRONIC DISEASE;
COGNITIVE THERAPY;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MALE;
MEMORY DISORDERS;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT DROPOUTS;
PSYCHIATRIC STATUS RATING SCALES;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
|
EID: 74249117086
PISSN: 00333190
EISSN: None
Source Type: Journal
DOI: 10.1159/000276378 Document Type: Letter |
Times cited : (10)
|
References (6)
|